Serge Bodart
Chief Commercial Officer, International Drug Development Institute (IDDI)
Serge Bodart has worked in the pharmaceutical industry for 20 years. He co-founded SYMFO, a European-based electronic patient reported outcome (ePRO) provider, where he has been involved in all aspects of the electronic clinical outcome assessments (eCOA) life cycle from concept to commercialization. As an internationally recognized thought leader, he has acted as the eCOA subject matter expert and scientific advisor for companies such as Biomedical Systems, mProve, Bracket Global, and Signant Health. In his career, he also gained extensive international expertise in business development. He currently serves as chief commercial officer at IDDI, a regulatory statistics CRO based in Raleigh, NC, and in Belgium.
Talk to Serge about these topics and more:
- Best practices on implementation of eCOA in clinical trials
- Marketing in life sciences
- How to select the CRO that best suits your clinical trial
Ready to Connect?
Would you like to invite a life science expert to participate in your next piece, program, panel, or partnership? Our team is standing by to help connect you to the right source and topic:
Save this page as a PDF
